IGF2BP1 directly recognizes and binds to the m6A site on CPT1A mRNA, increasing its stability and mediating IGF2BP1-induced breast cancer metastasis; this mechanism has been verified in clinical samples [99]. This evidence concerns the gene IGF2BP1 and breast carcinoma.